Logo image of OMGA

OMEGA THERAPEUTICS INC (OMGA) Stock News

NASDAQ:OMGA - Nasdaq - US68217N1054 - Common Stock - Currency: USD

0.2111  -0.02 (-8.14%)

Premarket: 0.2097 0 (-0.66%)

OMGA Latest News, Press Relases and Analysis

News Image
a day ago - Chartmill

What's going on in today's after hours session

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

News Image
6 days ago - Chartmill

Thursday's pre-market session: top gainers and losers

Wondering what's happening in Thursday's pre-market session? Find an overview in this article.

News Image
6 days ago - Chartmill

Wondering what's happening in today's after-hours session?

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

News Image
7 days ago - Chartmill

Unusual volume stocks in Wednesday's session

Discover the stocks with unexpected trading volume in today's session on the US markets.

News Image
7 days ago - Chartmill

Wednesday's pre-market session: top gainers and losers

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

News Image
7 days ago - Chartmill

Which stocks are moving after the closing bell on Tuesday?

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

News Image
8 days ago - Chartmill

Tuesday's session: top gainers and losers

Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

News Image
8 days ago - Chartmill

These stocks are making the most noise in today's session.

These stocks are making the most noise in today's session. Stay tuned for the latest updates!

News Image
8 days ago - Chartmill

These stocks have an unusual volume in today's session

On Tuesday, there are stocks with unusual volume. Let's take a look.

News Image
8 days ago - Chartmill

What's going on in today's session

Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.

News Image
9 days ago - Chartmill

Which stocks have an unusual volume on Monday?

Unusual volume stocks are being observed in Monday's session.

News Image
11 days ago - Chartmill

Wondering what's happening in today's after-hours session?

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

News Image
15 days ago - Chartmill

Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

News Image
15 days ago - Chartmill

Tuesday's session: top gainers and losers

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

News Image
15 days ago - Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session.

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

News Image
15 days ago - Chartmill

Discover the top movers in Tuesday's pre-market session.

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

News Image
3 months ago - Omega Therapeutics

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results

Established clinical proof-of-mechanism and validation of epigenomic controllers as potential new class of medicines from completed Phase 1 MYCHELANGELO™ I...

News Image
4 months ago - Omega Therapeutics

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering...